Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.

Journal article

OBJECTIVE: GH replacement is widely used in the management of patients with adult-onset (AO)-GH deficiency (GHD). In most cases, AO-GHD arises as a result of pituitary/peripituitary tumours and/or their treatment, but the effect of GH replacement on recurrence/regrowth of these tumours is unknown. The aim of this study was to examine the effect of GH replacement in a group of patients with primary tumours of the parasellar region, many of which (e.g. craniopharyngioma, glioma or germ cell tum...

Expand abstract

Authors: Chung, T; Drake, WM; Evanson, J; Walker, D; Plowman, P

• Publication status: Published
• Journal: Clinical endocrinology
• Volume: 63
• Issue: 3
• Pages: 274-279
• Publication date: 2005-09-01
• DOI: 10.1111/j.1365-2265.2005.02338.x
• EISSN: 1365-2265
• ISSN: 0300-0664
• Language: English
• Keywords: Brain Neoplasms; Combined Modality Therapy; Germinoma; Hormone Replacement Therapy; Neoplasm Recurrence, Local; Female; Middle Aged; Glioma; Follow-Up Studies; Pituitary Irradiation; Humans; Growth Hormone; Adult; Craniopharyngioma; Magnetic Resonance Imaging; Male; Brain; Hypopituitarism